Authors:
Ponten, F
Lindman, H
Bostrom, A
Berne, B
Bergh, J
Citation: F. Ponten et al., Induction of p53 expression in skin by radiotherapy and UV radiation: A randomized study, J NAT CANC, 93(2), 2001, pp. 128-133
Authors:
Ciray, I
Lindman, H
Astrom, KGO
Bergh, J
Ahlstrom, KH
Citation: I. Ciray et al., Early response of breast cancer bone metastases to chemotherapy evaluated with MR imaging, ACT RADIOL, 42(2), 2001, pp. 198-206
Authors:
Lindman, H
Jansson, T
Arnberg, H
Bergh, J
Einarsson, R
Citation: H. Lindman et al., Serum markers TPS, TPA and CA 15-3 as monitors of chemotherapy in patientswith metastatic breast cancer, J TUMOR M, 15(3), 2000, pp. 177-186
Citation: R. Einarsson et al., Use of TPS and CA 15-3 assays for monitoring chemotherapy in metastatic breast cancer patients, ANTICANC R, 20(6D), 2000, pp. 5089-5093
Authors:
Bergh, J
Wiklund, T
Erikstein, B
Lidbrink, E
Lindman, H
Malmstrom, P
Kellokumpu-Lehtinen, P
Bengtsson, NO
Soderlund, G
Anker, G
Wist, E
Ottosson, S
Salminen, E
Ljungman, P
Holte, H
Nilsson, J
Blomqvist, C
Wilking, N
Citation: J. Bergh et al., Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial, LANCET, 356(9239), 2000, pp. 1384-1391